DexCom

Federal Judge Decides Against Dexcom in Patent Infringement Case Over Glucose Monitor Technology

by

Wilmington, Delaware — A recent legal decision has marked a significant development in the medical technology industry, as Dexcom Inc. has been found to have infringed on a glucose monitor patent held by an Abbott Laboratories unit. This ruling by a Delaware judge resolved a previously undecided matter left by a federal jury in March, which had been unable to reach a verdict on the case. The dispute centers on Dexcom’s use of specific patented technology crucial to glucose monitoring devices that play a vital role in diabetes management. These devices continually measure the glucose … Read more

Urgent Investor Alert: Participate in the DexCom, Inc. Class Action Lawsuit by October 2024, Legal Firm Levi & Korsinsky Offers Guidance on Rights – DXCM

by

New York, NY – A recent class-action lawsuit filed against DexCom, Inc., a prominent player in the diabetes management technology sector, claims that the company engaged in practices which may have misled investors. The suit centers on possible violations of federal securities laws. According to the law firm Levi & Korsinsky, the lead plaintiff filings must be submitted by October 21, 2024. Shareholders who incurred damages from investments in DexCom’s stock during a specified period are eligible to discuss their rights and potentially participate in the lawsuit. The allegations suggest that DexCom may have provided … Read more